BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 29, 2019
View Archived Issues
Outside of cell, intracellular enzyme is HER2 inhibitor
Read More
Relaxation Rx for hypertrophic cardiomyopathy
Read More
Neurogenic pain receptor identified
Read More
Bacterial virulence factor contributes to brain damage in AD
Read More
New sphingosine 1-phosphate receptor antagonists reported by Galapagos
Read More
Sanofi patents new antimalarials
Read More
Inflazome describes NLRP3 inflammasome inhibitors
Read More
Peking University discovers STAT3 inhibitors
Read More
Selection Bioscience patents indoleamine 2,3-dioxygenase 1 inhibitors
Read More
Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine describe RORC agonists/inverse agonists
Read More
FDA approves I-Mab's IND to initiate phase I/Ib study of TJC-4
Read More
First volunteer dosed in phase I study of HBV therapy DCR-HBVS
Read More
LJ-2618, a new selenonucleoside, inhibits prostate cancer tumor growth in vivo
Read More
GB-1211 begins first-in-human trial in healthy volunteers and subjects with NASH and liver fibrosis
Read More
Enyo Pharma initiates phase IIa study of EYP-001a in NASH
Read More
Horizon Discovery partners with Rutgers University on base editing platform
Read More
MedImmune studies MEDI-7247 in phase I/Ib trial for advanced or metastatic solid tumors
Read More
Rocket studies RP-L201 in pediatric patients with severe leukocyte adhesion deficiency-I
Read More
Phase I data presented for mAb114 monoclonal antibody for treating Ebola virus
Read More
Small molecule targets the most common genetic cause of ALS
Read More
Topline results from second phase III study of tanezumab in OA pain
Read More
Triphase enters strategic collaboration with Celgene for TRPH-395
Read More
Chinese IND clearance for CARsgen's GPC3-CAR-T cells for solid tumors
Read More